EVALUATION OF POISOINING CASES ACCEPTED AT INTENSIVE CARE UNIT5 YEAR RETROSPECTİVE ANALYSİS

Journal Title: World Journal of Pharmaceutical Research - Year 2019, Vol 8, Issue 3

Abstract

Intoxication has been an important problem concerned social groups closely since old ages. According to Ministry of Health, in 2001, it was figured out that 11 672 people consulted in health institutes because of the intoxication. Nowadays, most of these cases occur by reason of medical drugs, recreational drug, industrial and agricultural toxics. In this retrospective study, between 2007-2011, we followed up individual properties, etiological factors, the period of admission to the hospital after intoxication, the period in intensive care unit, patients clinical situiation during intensive care, type of toxicity, seasonal distribution of the acute poisoning cases addmitted to the intensive care unit and these factors were evaluated if they were related to mortality or not. Last 5 years, the number patients admitted intensive care unit with the reason of intoxication was 114. Female male ratio was 45,6 /54,4%. Single married ratio was 35/65%. Their average age was 36,1. Cause of the toxication was mostly medicines 52,6%. Herbicide was the second reason (32,5%). The main reason of toxication was suicide (77%). The most common way of poisoning was oral ingestion (90,4%) and 75,2% of patients used actived carbon in initial treatment. Only 15,3% of patients needed mechanic ventilator treatment and average day was 4 days. Glaskow Come Scale 13,13 on admission APACHE II score was 6,6. Mortality rate was 9,6%. There was no seasonal variation. Mortality rate was higher in the groups which, the admission time was more than 12 hours, in cases poisoned by methyl alcohol, needed mechanic ventilator, low GKS was and high APACHE II on admission. As a result, this retrospective study shows paralel results poisoned patient profile in Turkey. The most common cause of poisoning is medical drugs. As a predictor of mortality; patients GKS and APACHE scores on addmition, type of toxicity, by which way it is taken and the time of the admission to the hospital may lead the way.

Authors and Affiliations

Dr. Aslı Mete

Keywords

Related Articles

A REVIEW ON SIDDHA HERBAL FORMULATION DEVA CHOORANAM FOR IMPROVING THE QOL IN ACQUIRED IMMUNO DEFICIENCY SYNDROME (AIDS)

The ancient Siddha system of medicine has its origin right from the genesis of mankind. According to this medical system, herbs and human have proved their inseparable unification time and again all through the ages. Eit...

THE ROLE OF MORINGA OLEIFERA EXTRACT IN MAINTENANCE OF BRAIN AND TESTIS TISSUES AGAINST AFLATOXIN B1 (AFB1) TOXICITY ON LIGHT OF MOLECULAR GENETIC AND HISTOLOGICAL STUDIES IN RATS

Moringa oleifera is a promising plant that accounts for the medicinal uses such as a vital antioxidants, antibiotics and nutrients including vitamins and minerals. The present study was conducted to quantify the genotoxi...

A REVIEW ON: IMPLIMENTATION OF YOGIC DIET IN TODAY’S ERA

We don’t eat to be healthy, we don’t eat to live better, we just eat for taste. So, don’t make your body a graveyard or a junkyard. Keeping this in mind Acharya Charaka has stated three sub pillars of the body- Aahara, N...

EVALUATION OF PROSTATE CANCER HEALTH-RELATED QUALITY OF LIFE (SPECIFIC SCALE) AMONG A SAMPLE IN BAGHDAD CITY

Objectives: this study amid to identify and study most properties of the specific health-related quality-of-life (HRQoL) in men with prostate cancer, and to find out relationships among distribution of an overall assessm...

PRIMARY DYSMENORRHEA AMONG CONSTANTINE 1 UNIVERSITY STUDENTS

Objective: To evaluate the primary dysmenorrhea among Constantine 1 university students. Study design: The cross-sectional study was conducted at Constantine 1 University. A multiple-choice questionnaire was administered...

Download PDF file
  • EP ID EP667071
  • DOI -
  • Views 129
  • Downloads 0

How To Cite

Dr. Aslı Mete (2019). EVALUATION OF POISOINING CASES ACCEPTED AT INTENSIVE CARE UNIT5 YEAR RETROSPECTİVE ANALYSİS. World Journal of Pharmaceutical Research, 8(3), 106-119. https://europub.co.uk/articles/-A-667071